Bicycle Therapeutics Plans To Present Data At SABCS; Abstract Outlines Data Showing Enhanced Anti-Tumor Activity Of Zelenectide Pevedotin Monotherapy In Triple-negative Breast Cancer Patients With NECTIN4 Gene Amplification
Bicycle Therapeutics Plans To Present Data At SABCS; Abstract Outlines Data Showing Enhanced Anti-Tumor Activity Of Zelenectide Pevedotin Monotherapy In Triple-negative Breast Cancer Patients With NECTIN4 Gene Amplification
bicycle therapeutics計劃在SABCS上展示數據;摘要概述顯示Zelenectide Pevedotin單藥在NECTIN4基因擴增的三陰性乳腺癌患者中表現出增強的抗腫瘤活性
Bicycle Therapeutics Plans To Present Data At SABCS; Abstract Outlines Data Showing Enhanced Anti-Tumor Activity Of Zelenectide Pevedotin Monotherapy In Triple-negative Breast Cancer Patients With NECTIN4 Gene Amplification
bicycle therapeutics計劃在SABCS上展示數據;摘要概述顯示Zelenectide Pevedotin單藥在NECTIN4基因擴增的三陰性乳腺癌患者中表現出增強的抗腫瘤活性
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。